Friday, March 17, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – June 1, 2014

by Stephanie Lizotte
June 1, 2014

Global health leaders again put off verdict on eliminating smallpox | Ebola cases in Sierra Leone triple, to 50 | Novel heartland virus responsible for two deaths in the US | Finding its niche in biodefense: Bioprinting | Scientists find killer chemical for virus behind SARS and MERS | How to succeed in translational science | Triumphs, trials, and tribulations of the global response to MERS coronavirus | Four DARPA projects that could be bigger than the internet | CDC: Meeting did not spread MERS | Tests show high H7N9 antibodies in Chinese poultry workers | European Union CBRN medical countermeasure preparedness | Mystery of 1918 pandemic flu virus solved | Pandemics: Who should be given life-saving treatment first? | Male scent may compromise biomedical research | Deadly pig virus re-infects U.S. farm, fuels supply fears | Funding cuts threaten public health and worry officials | NYC ricin plotter also stockpiled firearms, bomb materials

See what we’re reading this week at Global Biodefense on topics like bioprinting and biodefense, delays to destruction of last stocks of smallpox, Heartland virus deaths and more…

Global health leaders again put off verdict on eliminating smallpox (NTI GSN)

Ebola cases in Sierra Leone triple, to 50 (CIDRAP)

Novel Heartland virus responsible for two deaths in the US (UPMC Clinicians’ Biosecurity News)

Finding its niche in biodefense: Bioprinting (Pandora Report)

Scientists find killer chemical for virus behind SARS and MERS (The Conversation)

How to succeed in translational science (Science)

Triumphs, trials, and tribulations of the global response to MERS coronavirus (UPMC CHS)

Four DARPA projects that could be bigger than the internet (Defense One)

CDC: Meeting did not spread MERS (The Scientist)

Tests show high H7N9 antibodies in Chinese poultry workers (CIDRAP)

European Union CBRN medical countermeasure preparedness (CBRNePortal)

Mystery of 1918 pandemic flu virus solved (University of Arizona)

Pandemics: Who should be given life-saving treatment first? (HSNW)

Male scent may compromise biomedical research (Science)

Deadly pig virus re-infects U.S. farm, fuels supply fears (Reuters)

Funding cuts threaten public health and worry officials (EM)

NYC ricin plotter also stockpiled firearms, bomb materials (NTI GSN)

Tags: Agro-DefenseH7N9PandemicRicinStrategic National Stockpile

Related Posts

Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Biodefense Headlines – 10 January 2023
News Scan

Biodefense Headlines – 10 January 2023

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy